Literature DB >> 27060071

Complete reversal of hypertensive cardiomyopathy after initiating combined antihypertensive therapy.

Marijn J Holl1, Sweder W van de Poll1, Michelle Michels2.   

Abstract

Hypertensive cardiomyopathy is a common complication of hypertension, with a prevalence ranging from 12% to 26%. It is associated with an increased cardiac mortality and morbidity. Lifestyle changes and antihypertensive therapy usually have a significant, but relatively small effect on left ventricular hypertrophy (LVH), which is associated with a reduction in cardiovascular risk. In this paper, we describe a 39-year-old woman with severe LVH. On transthoracic echocardiogram there was concentric LVH, systolic function was a mildly reduced and there was diastolic dysfunction grade III. After only 6 months of therapy with a combination of antihypertensive agents, the left ventricular mass index was reduced by 29%, systolic function was normal and the diastolic dysfunction improved to grade I. This paper shows that in hypertensive cardiomyopathy, even severe LVH can be completely reversible. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27060071      PMCID: PMC4840654          DOI: 10.1136/bcr-2015-212908

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

Review 1.  A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension.

Authors:  Arnfried U Klingbeil; Markus Schneider; Peter Martus; Franz H Messerli; Roland E Schmieder
Journal:  Am J Med       Date:  2003-07       Impact factor: 4.965

Review 2.  Recommendations for chamber quantification.

Authors:  Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack Shanewise; Scott Solomon; Kirk T Spencer; Martin St John Sutton; William Stewart
Journal:  Eur J Echocardiogr       Date:  2006-02-02

Review 3.  Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies.

Authors:  Robert H Fagard; Hilde Celis; Lutgarde Thijs; Stijn Wouters
Journal:  Hypertension       Date:  2009-09-21       Impact factor: 10.190

4.  Prevalence and correlates of echocardiographic determined left ventricular hypertrophy in 2318 asymptomatic middle-aged men: the ECCIS project. Epidemiolgia e Clinica della Cardiopatia Ischemica Silente.

Authors:  D Antoniucci; F Seccareccia; A Menotti; E V Dovellini; P L Prati; F Rovelli; P F Fazzini
Journal:  G Ital Cardiol       Date:  1997-04

5.  Antihypertensive therapy reduces increased plasma levels of adrenomedullin and brain natriuretic peptide concomitant with regression of left ventricular hypertrophy in a patient with malignant hypertension.

Authors:  T Nishikimi; H Matsuoka; K Ishikawa; F Yoshihara; Y Kawano; K Kitamura; Y Saito; K Kangawa; H Matsuo; T Omae
Journal:  Hypertens Res       Date:  1996-06       Impact factor: 3.872

6.  Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death.

Authors:  A W Haider; M G Larson; E J Benjamin; D Levy
Journal:  J Am Coll Cardiol       Date:  1998-11       Impact factor: 24.094

7.  Regression of echocardiographic left ventricular hypertrophy after 2 years of therapy reduces cardiovascular risk in patients with essential hypertension.

Authors:  Sante D Pierdomenico; Domenico Lapenna; Franco Cuccurullo
Journal:  Am J Hypertens       Date:  2008-02-07       Impact factor: 2.689

8.  Prevalence of left ventricular hypertrophy in a hypertensive population.

Authors:  J Tingleff; M Munch; T J Jakobsen; C Torp-Pedersen; M E Olsen; K H Jensen; T Jørgensen; M Kirchoff
Journal:  Eur Heart J       Date:  1996-01       Impact factor: 29.983

9.  Effect of antihypertensive monotherapy and combination therapy on arterial distensibility and left ventricular mass.

Authors:  Joel M Neutel; David H G Smith; Michael A Weber
Journal:  Am J Hypertens       Date:  2004-01       Impact factor: 2.689

10.  Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS).

Authors:  P R Liebson; G Grandits; R Prineas; S Dianzumba; J M Flack; J A Cutler; R Grimm; J Stamler
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.